Skip to content
Trial Agents

Colpitts

Colpitts is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

3distinct trials
3recorded service labels
1trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 3 of 3 trials · Latest update first

A Phase II/III, multicentre, 8-week run-in phase followed by a 12- week, prospective, parallel-group, double-blind, randomized withdrawal, placebo-controlled study, with a 52 week open label extension, to evaluate the efficacy and safety of daily 1.5 to 3.5 mg basimglurant in patients with pain associated with trigeminal neuralgia with suboptimal response to their current anti-pain therapy

Sponsor Noema Pharma AG

Start (EU)
Latest update
Estimated end

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia

Sponsor Ionis Pharmaceuticals Inc.

Start (EU)
Latest update
Estimated end
Operational learnings available3 trial-level findings · Read insights
  • The screening period was extended to accommodate potential scheduling challenges for MRI assessments, repeat laboratory assessments, and genetic testing for familial chylomicronemia syndrome.
  • Eligibility criteria were revised to specify diabetes-related exclusions, permit participants with previously treated non-active hepatitis C infection, clarify malignancy and beta-blocker criteria, and exclude recent or anticipated major changes in triglyceride-lowering therapies.
  • Women of childbearing potential were required to use highly effective contraception from informed consent until at least 17 weeks after the last study-drug dose, based on updated pharmacokinetic modeling.

These findings describe the trial, not the service provider’s performance or responsibility.

J2G-MC-JZJC: LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Sponsor Eli Lilly & Co.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Colpitts?

The 2026-10-09 snapshot links Colpitts to 3 distinct CTIS trials. Recorded services include Patient Referral, Recruitment, Screening, and/or Retention, Patient Travel reimbursement, Subject Transportation. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Colpitts?

The most frequently recorded therapeutic areas are Cardiology, Metabolic Disorders, Neurology, Pain Medicine. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Colpitts conducted?

The linked trials record locations in 17 countries, including Spain, Italy, Belgium, Germany, France. These are trial locations, not confirmed office locations or countries where Colpitts delivered services.

What can this page tell me about Colpitts's trial experience?

Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Colpitts. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Colpitts

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.